-
Correction to: Family matters: health policies to tackle cardiomyopathies across Europe. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-19
-
Covered Stent Correction for Sinus Venosus Atrial Septal Defects, an Emerging Alternative to Surgical Repair: Results of an International Registry. Circulation (IF 35.5) Pub Date : 2024-12-19 Eric Rosenthal,Shakeel A Qureshi,Kothandam Sivakumar,Matthew Jones,San-Fui Yong,Saleha Kabir,Pramod Sagar,Puthiyedath Thejaswi,Sebastien Hascoet,Clement Batteux,Younes Boudjemline,Ziyad M Hijazi,Jamil A Aboulhosn,Daniel S Levi,Morris M Salem,Edwin Francis,Aleksander Kempny,Alain Fraisse,Carles Bautista-Rodriguez,Kevin Walsh,Damien Kenny,Brian Traynor,Salim N Al Maskari,James R Bentham,László Környei
BACKGROUND Covered stent correction for a sinus venosus atrial septal defect (SVASD) was first performed in 2009. This innovative approach was initially viewed as experimental and was reserved for highly selected patients with unusual anatomic variants. In 2016, increasing numbers of procedures began to be performed, and in several centers, it is now offered as a standard of care option alongside surgical
-
2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke: A Report of the American College of Cardiology Solution Set Oversight Committee J. Am. Coll. Cardiol. (IF 21.7) Pub Date : 2024-12-17 Michael T. Spooner, Steven R. Messé, Seemant Chaturvedi, Monika M. Do, Ty J. Gluckman, Janet K. Han, Andrea M. Russo, Sherry J. Saxonhouse, Newton B. Wiggins
Section snippets Solution Set Oversight CommitteeNicole M. Bhave, MD, FACC, ChairNiti R. Aggarwal, MD, FACCKatie Bates, ARNP, DNPJohn P. Erwin III, MD, FACCMartha Gulati, MD, MS, FACCDharam J. Kumbhani, MD, SM, FACCGurusher S. Panjrath, MBBS, FACCBarbara Wiggins, PharmD, FACCMegan Coylewright, MD, MPH, FACC, Ex Officio Table of Contents 1.Introduction 2 2.Assumptions and Definitions 3 2.1.General Clinical
-
Wine consumption and cardiovascular health: the unresolved French paradox and the promise of objective biomarkers. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-18 Giovanni de Gaetano,Simona Costanzo,Augusto Di Castelnuovo
-
Urinary tartaric acid as a biomarker of wine consumption and cardiovascular risk: the PREDIMED trial Eur. Heart J. (IF 37.6) Pub Date : 2024-12-18 Inés Domínguez-López, Rosa M Lamuela-Raventós, Cristina Razquin, Camila Arancibia-Riveros, Polina Galkina, Jordi Salas-Salvadó, Ángel M Alonso-Gómez, Montserrat Fitó, Miquel Fiol, José Lapetra, Enrique Gómez-Gracia, José V Sorlí, Miguel Ruiz-Canela, Olga Castañer, Liming Liang, Lluis Serra-Majem, Frank B Hu, Emilio Ros, Miguel Ángel Martínez-González, Ramon Estruch
Background and Aims Moderate wine consumption has been associated with lower cardiovascular disease (CVD) risk in older populations. However, wine consumption information through self-reports is prone to measurement errors inherent to subjective assessments. The aim of this study was to evaluate the association between urinary tartaric acid, an objective biomarker of wine consumption, and the rate
-
ACKR1hiECs Promote Aortic Dissection Through Adjusting Macrophage Behavior. Circ. Res. (IF 16.5) Pub Date : 2024-12-18 Yayu Wang,Xiong Jia,Yifei Zhang,Bin Zhang,Yazhe Zhou,Xiaoru Li,Xiaoying Zhu,Jinquan Xia,Jun Ren,Chang Zou,Qijun Zheng
BACKGROUND Type A aortic dissection (TAAD) is a life-threatening condition characterized by complex pathophysiology, in which macrophages play a critical but not yet fully understood role. This study focused on the role of endothelial cells with elevated expression of ACKR1 (atypical chemokine receptor 1) and their interaction with proinflammatory macrophages in TAAD development. METHODS AND RESULTS
-
Follistatin From hiPSC-Cardiomyocytes Promotes Myocyte Proliferation in Pigs With Postinfarction LV Remodeling. Circ. Res. (IF 16.5) Pub Date : 2024-12-18 Yuhua Wei,Gregory Walcott,Thanh Nguyen,Xiaoxiao Geng,Bijay Guragain,Hanyu Zhang,Akazha Green,Manuel Rosa-Garrido,Jack M Rogers,Daniel J Garry,Lei Ye,Jianyi Zhang
BACKGROUND When human induced pluripotent stem cells (hiPSCs) that CCND2-OE (overexpressed cyclin-D2) were differentiated into cardiomyocytes (CCND2-OEhiPSC-CMs) and administered to the infarcted hearts of immunodeficient mice, the cells proliferated after administration and repopulated >50% of the scar. Here, we knocked out human leukocyte antigen class I and class II expression in CCND2-OEhiPSC-CMs
-
Preventing Declines in Cardiovascular Health From Childhood: Never Too Early for Heart Health. JAMA Cardiol. (IF 14.8) Pub Date : 2024-12-18 Natalie A Cameron,Norrina B Allen
-
Potassium Nitrate in Heart Failure With Preserved Ejection Fraction JAMA Cardiol. (IF 14.8) Pub Date : 2024-12-18 Payman Zamani, Sanjiv J. Shah, Jordana B. Cohen, Manyun Zhao, Wei Yang, Jessica L. Afable, Maria Caturla, Hannah Maynard, Bianca Pourmussa, Cassandra Demastus, Ipsita Mohanty, Michelle Menon Miyake, Srinath Adusumalli, Kenneth B. Margulies, Stuart B. Prenner, David C. Poole, Neil Wilson, Ravinder Reddy, Raymond R. Townsend, Harry Ischiropoulos, Thomas P. Cappola, Julio A. Chirinos
ImportanceNitric oxide deficiency may contribute to exercise intolerance in patients with heart failure with preserved ejection fraction (HFpEF). Prior pilot studies have shown improvements in exercise tolerance with single-dose and short-term inorganic nitrate administration.ObjectiveTo assess the impact of chronic inorganic nitrate administration on exercise tolerance in a larger trial of participants
-
Trajectory of Cardiovascular Health Across Childhood and Adolescence JAMA Cardiol. (IF 14.8) Pub Date : 2024-12-18 Izzuddin M. Aris, Sheryl L. Rifas-Shiman, Wei Perng, Li Yi, Sarah D. de Ferranti, Marie-France Hivert, Emily Oken
ImportanceThe American Heart Association put forth the Life’s Essential 8 construct to assess cardiovascular health (CVH) based on 8 behavioral and health factors. Few studies have characterized the natural history of CVH in early life or identified its sociodemographic determinants.ObjectiveTo characterize CVH trajectories across childhood and adolescence and identify associations with sociodemographic
-
Chest Pain in a Middle-Aged Man JAMA Cardiol. (IF 14.8) Pub Date : 2024-12-18 Qinghua Chang, Zhaolong Xu, Renguang Liu
A man in his mid-50s presented with chest pain lasting 30 minutes. The initial electrocardiogram showed type A preexcitation syndrome, with obvious ST-segment depression in leads V3 through V5 and positive delta wave. What would you do next?
-
Endothelial Cell TRPV4 Channels Turn to the Dark Side During Hypertension. Hypertension (IF 6.9) Pub Date : 2024-12-18 Alejandro Mata-Daboin,Jonathan H Jaggar
-
Targeting macrophage–fibroblast interactions in the failing heart Nat. Rev. Cardiol. (IF 41.7) Pub Date : 2024-12-16 Nikolaos G. Frangogiannis
-
Lifetime risk of lower extremity peripheral arterial disease: a Danish nationwide longitudinal study Eur. Heart J. (IF 37.6) Pub Date : 2024-12-17 Mette Søgaard, Christian-Alexander Behrendt, Nikolaj Eldrup, Flemming Skjøth
Background and Aims Lower extremity peripheral arterial disease (PAD) presents a substantial disease burden, yet lifetime estimates remain scant. This nationwide study quantified the lifetime risk of PAD and its clinical outcomes in Denmark. Methods This cohort study included 4 275 631 individuals in Denmark aged 40–99 years between 1998 and 2018. We estimated the lifetime risk using a modified survival
-
Diffusion tensor imaging to assess myocardial microstructure after infarction by magnetic resonance. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-17 Erica Dall'Armellina,Sven Plein
-
METTL4-Mediated Mitochondrial DNA N6-Methyldeoxyadenosine Promoting Macrophage Inflammation and Atherosclerosis. Circulation (IF 35.5) Pub Date : 2024-12-17 Longbin Zheng,Xiang Chen,Xian He,Huiyuan Wei,Xinyu Li,Yongkang Tan,Jiao Min,Minghong Chen,Yunjia Zhang,Mengdie Dong,Quanwen Yin,Mengdie Xue,Lulu Zhang,Da Huo,Hong Jiang,Tingyou Li,Fei Li,Xin Wang,Xuesong Li,Hongshan Chen
BACKGROUND Mitochondrial dysfunction is a key factor in the development of atherogenesis. METTL4 (methyltransferase-like protein 4) mediates N6- methyldeoxyadenosine (6mA) of mammalian mitochondrial DNA (mtDNA). However, the role of METTL4-mediated mitoepigenetic regulation in atherosclerosis is still unknown. This study aims to investigate the potential involvement of METTL4 in atherosclerosis, explore
-
SGLT2 Inhibition Induces Cardioprotection by Increasing Parasympathetic Activity. Circ. Res. (IF 16.5) Pub Date : 2024-12-17 Maryna V Basalay,Alla Korsak,Zhenhe He,Alexander V Gourine,Sean M Davidson,Derek M Yellon
-
Meis transcription factors regulate cardiac conduction system development and adult function Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-17 Noelia Muñoz-Martín, Ana Simon-Chica, Covadonga Díaz-Díaz, Vanessa Cadenas, Susana Temiño, Isaac Esteban, Andreas Ludwig, Barbara Schormair, Juliane Winkelmann, Veronika Olejnickova, David Sedmera, David Filgueiras-Rama, Miguel Torres
Aims The Cardiac Conduction System (CCS) is progressively specified during development by interactions among a discrete number of Transcriptions Factors that ensure its proper patterning and the emergence of its functional properties. Meis genes encode homeodomain transcription factors (TFs) with multiple roles in mammalian development. In humans, Meis genes associate with congenital cardiac malformations
-
SerpinB1 targeting safeguards against pathological cardiac hypertrophy and remodelling by suppressing cardiomyocyte pyroptosis and inflammation initiation Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-17 Cong Lan, Gangyao Fang, Xiuchuan Li, Xiao Chen, Yingmei Chen, Tao Hu, Xuenan Wang, Huiling Cai, Jiajin Hao, Haoran Li, Yan Zhang, Ke Peng, Zaicheng Xu, Dachun Yang, Xia Kang, Qian Xin, Yongjian Yang
Aims While the pivotal role of inflammation in pathological cardiac hypertrophy and remodelling is widely acknowledged, the mechanisms triggering inflammation initiation remain largely obscure. This study aims to elucidate the role and mechanism of serpin family B member 1 (SerpinB1) in pro-inflammatory cardiomyocyte pyroptosis, heart inflammation, and cardiac remodelling. Methods and results C57BL/6J
-
Maternal Hypertension Aggravates Vascular Dysfunction After Injury in Male Adult Offspring Through Transgenerational Transmission of N6-Methyladenosine. Hypertension (IF 6.9) Pub Date : 2024-12-17 Dezhong Zheng,Jiayi Jiang,Anna Shen,Yixiang Zhong,Yi Zhang,Jiancheng Xiu
BACKGROUND Whether maternal hypertension contributes to the enhanced susceptibility to vascular remodeling in adult offspring through epigenetic mechanisms remains unclear. We aimed to address this gap in the literature using a transgenerational mouse model. METHODS Gestational hypertension was induced in pregnant mice using chronic angiotensin II infusion. Blood pressure was monitored using the tail-cuff
-
Navigating cardiotoxicity risk in cancer therapy: the importance of the HFA-ICOS score. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-16 Lloyd E Butel-Simoes,Doan T M Ngo,Aaron L Sverdlov
-
Reimagining heart teams: advanced cardiovascular collaboration through virtual reality in the metaverse. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-16 Ioannis Skalidis,Panagiotis Antiochos,Dimitri Arangalage
-
Focus on trials in dyslipidaemias, arrhythmias, cardiomyopathies, and interventional cardiology. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-16 Filippo Crea
-
Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management. Circulation (IF 35.5) Pub Date : 2024-12-16 Daijiro Tomii,Thomas Pilgrim,Michael A Borger,Ole De Backer,Jonas Lanz,David Reineke,Matthias Siepe,Stephan Windecker
Aortic stenosis (AS) and coronary artery disease (CAD) frequently coexist and share pathophysiological mechanisms. The proportion of patients with AS and CAD requiring revascularization varies widely because of uncertainty about best clinical practices. Although combined surgical aortic valve replacement and coronary artery bypass grafting has been the standard of care, management options in patients
-
Letter by Wang and Huang Regarding Article, "Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism". Circulation (IF 35.5) Pub Date : 2024-12-16 Hai-Yan Wang,Feng Huang
-
ET-3/ETBR Mediates Na+-Activated Immune Signaling and Kidney Lymphatic Dynamics. Circ. Res. (IF 16.5) Pub Date : 2024-12-16 Ashley L Mutchler,Jianyong Zhong,Hai-Chun Yang,Shilin Zhao,Rachelle Crescenzi,Shannon Taylor,Roy L Rao,Elaine L Shelton,Annet Kirabo,Valentina Kon
BACKGROUND Lymphatic collecting vessels in the kidney are critical in clearing interstitial fluid, macromolecules, and infiltrating immune cells. Dysfunction of the lymphatic vessels can disrupt this process and exacerbate injury-associated inflammation in many disease conditions. We previously found that sodium accumulates within the kidney interstitium during proteinuric kidney injury and elevated
-
Correction to: Cellular mechanisms of oligoclonal vascular smooth muscle cell expansion in cardiovascular disease. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-12-16
-
A rare aortic pseudoaneurysm-right atrial fistula. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-14 Yankai Mao,Jiwen Li,Jie Han
-
Pump, pipes, filter, sugar, weight, and more: the pluripotent prowess of semaglutide. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-14 Subodh Verma,Francesco Cosentino,Mikhail N Kosiborod
-
Weekly Journal Scan: HELIOS-B sheds light on new therapeutic options for transthyretin amyloidosis with cardiomyopathy. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-14 Daniela Pedicino,Massimo Volpe
-
Weekly Journal Scan: The jury is still out on beta-blockers following acute myocardial infarction with preserved ejection fraction after the ABYSS trial. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-14 Daniela Pedicino,Massimo Volpe
-
Connecting the dots: the Mediterranean diet, neutrophil count, and atherosclerosis. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-14 Marta Guasch-Ferré
-
Cardiac Reprogramming and Gata4 Overexpression Reduce Fibrosis and Improve Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction. Circulation (IF 35.5) Pub Date : 2024-12-14 Yu Yamada,Taketaro Sadahiro,Koji Nakano,Seiichiro Honda,Yuto Abe,Tatsuya Akiyama,Ryo Fujita,Masashi Nakamura,Takashi Maeda,Yuta Kuze,Masaya Onishi,Masahide Seki,Yutaka Suzuki,Chikara Takeuchi,Yuka W Iwasaki,Kensaku Murano,Mamiko Sakata-Yanagimoto,Shigeru Chiba,Hideyuki Kato,Hiroaki Sakamoto,Yuji Hiramatsu,Masaki Ieda
BACKGROUND Heart failure with preserved ejection fraction (HFpEF) is a major health concern. Pathological stimuli and interactions between cardiac fibroblasts (CFs) and other cell types may lead to cardiac fibrosis and diastolic dysfunction, which are hallmarks of HFpEF. Interstitial and perivascular cardiac fibrosis correlates with poor prognosis in HFpEF; however, mechanisms of fibrosis remain poorly
-
Understanding ezetimibe's role in lipid lowering and its limited impact on venous thromboembolism risk. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-13 Ioannis T Farmakis,Stavros V Konstantinides,Luca Valerio
-
Why couldn't lipid-lowering therapies of ezetimibe combined with statin further reduce the risk of venous thromboembolism? Eur. Heart J. (IF 37.6) Pub Date : 2024-12-13 Lingyan Lv
-
Baroreflex Sensitivity and Long-Term Dementia Risk in Older Adults. Hypertension (IF 6.9) Pub Date : 2024-12-13 Yuan Ma,Yiwen Zhang,Rikuta Hamaya,Berend E Westerhof,Hossam A Shaltout,Maryam Kavousi,Francesco Mattace-Raso,Albert Hofman,Frank J Wolters,Lewis A Lipsitz,M Arfan Ikram
BACKGROUND Increased blood pressure (BP) variability is linked to dementia risk, but the relationship between baroreflex sensitivity (BRS), a fundamental mechanism for maintaining stable BP, and dementia risk is undetermined. METHODS We tested the hypothesis that impaired BRS is associated with increased dementia risk in 1819 older adults (63% women; age, 71.0±6.3 years) from the community-based Rotterdam
-
Left atrial appendage closure after ablation: the best OPTION for patients with AF? Nat. Rev. Cardiol. (IF 41.7) Pub Date : 2024-12-11 Karina Huynh
Two studies presented at AHA 2024 Scientific Sessions describe the efficacy and safety of left atrial appendage closure after catheter ablation for atrial fibrillation and the 5-year outcomes of the largest randomized left atrial appendage closure trial to date comparing the safety and efficacy of two devices.
-
In focus: Bernhard Gerber takes on editorship of Cardiovascular Imaging. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-12 Judith Ozkan
-
Shaping the future of cardiovascular research: a focus on cardioimmunology. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-12 Soumaya Ben-Aicha,Emiel P C van der Vorst
-
Transcatheter Aortic Valve Replacement in Heart Failure, Reduced Ejection Fraction, and Moderate Aortic Stenosis J. Am. Coll. Cardiol. (IF 21.7) Pub Date : 2024-12-11 Patrick T. O’Gara
Section snippets Funding Support and Author DisclosuresThe author has reported that he has no relationships relevant to the contents of this paper to disclose.
-
Giving Cardiovascular Clinicians a Voice in Evidence Generation: A Collaboration Between FDA and JACC J. Am. Coll. Cardiol. (IF 21.7) Pub Date : 2024-12-11 Haider J. Warraich, Harlan M. Krumholz, Robert M. Califf
Section snippets Funding Support and Author DisclosuresDr Warraich has served on the medical advisory board for GoodRx. Dr Krumholz is the Editor-in-Chief of JACC; has received stock options for advisory roles from Element Science and Identifeye; has received payments for advisory roles from F-Prime; is a cofounder of and holds equity in Hugo Health, Refactor Health, and ENSIGHT-AI; and is associated
-
Rheumatic Valve Surgery in Sudan: Results in 7,449 Patients at the Salam Centre for Cardiac Surgery J. Am. Coll. Cardiol. (IF 21.7) Pub Date : 2024-12-11 Gina Portella, Liliane Chatenoud, Sofia Gatti, Alessandro C. Salvati, Lino Asta, Salvatore Lentini, Juha Puntila, Franco Masini, Sofia Redaelli, Alessandro Mocini, Suha Abdelwahab Abdallah, Sohayda Hussein Abdalla Abdalla, Nicoletta Erba, Elena Giovanella, Dimiana Raafat Shafig Saber, Daniela Rocchi, Manahel Badr Saad, Lorenzo Valgoi, Paolo Malerba, Luca Rolla, Martin Langer
Section snippets Study design and settingThis retrospective cohort includes all patients admitted for RHD surgery at the Salam Centre from April 2007 to December 2021, with follow-up of patients discharged alive evaluated up to July 2022. The Salam Centre7 admits about 80% of patients from Sudan and 20% from neighboring countries, as per agreement with the government. The hospital was built and is
-
In CASTLE-HTx Trial We Trust J. Am. Coll. Cardiol. (IF 21.7) Pub Date : 2024-12-11 Christian Sohns, Nassir F. Marrouche, Harry J.G.M. Crijns, Samuel Sossalla, Vanessa Sciacca, Jan G.P. Tijssen, Philipp Sommer
Section snippets Funding Support and Author DisclosuresDr Sohns has received research support and lecture fees from Medtronic, Abbott, Boston Scientific, and Biosense Webster; has served as a consultant for Medtronic, Boston Scientific, and Biosense Webster; and has received grant support from the Else Kröner-Fresenius-Stiftung and Deutsche Herzstiftung. Dr Marrouche has received grant support and
-
Incidental and Progressive Tobacco Smoking in Childhood and Subsequent Risk of Premature Cardiac Damage J. Am. Coll. Cardiol. (IF 21.7) Pub Date : 2024-12-11 Andrew O. Agbaje
Section snippets MethodsThe ALSPAC birth cohort investigates factors that influence childhood development and growth.5 Of the original cohort of 14,901 children enrolled in the ALSPAC, 4,026 (27%) attended the clinic visit at 24 years of age. Of these, 1,958 (49%) had echocardiograms performed. The current analysis included 1,931 young adults with complete smoking and echocardiographic measures at
-
Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry) J. Am. Coll. Cardiol. (IF 21.7) Pub Date : 2024-12-11 Paola Gargiulo, Federica Marzano, Mario Crisci, Rossella Marcucci, Dario Bruzzese, Alessandro Maloberti, Filippo Maria Sarullo, Gennaro Galasso, Ciro Indolfi, Giuseppe Musumeci, Antonella Corleto, Paolo Calabrò, Stefano Carugo, Gavino Casu, Amedeo Picciolo, Marco Matteo Ciccone, Claudio Bilato, Alberto Polimeni, Francesco Giallauria, Angelo Catalano, Pasquale Perrone Filardi
Section snippets MethodsCHOLINET is a single-country, multicenter, observational, prospective, phase 4 registry of Italian patients initiating inclisiran as part of clinical management. Reimbursement criteria (Italian Medicines Agency [AIFA], GU 231-03.10.2022) include patients at very high cardiovascular (CV) risk with LDL-C of ≥70 mg/dL on statin ± ezetimibe. Lipids were assessed at median of 17 days
-
Intraindividual Variability in Serial Lipoprotein(a) Concentrations Among Placebo-Treated Patients in the OCEAN(a)-DOSE Trial J. Am. Coll. Cardiol. (IF 21.7) Pub Date : 2024-12-11 Prakriti Gaba, Robert S. Rosenson, J. Antonio G. López, Gerald F. Watts, Thorsten M. Leucker, Julia F. Kuder, KyungAh Im, Helina Kassahun, Huei Wang, You Wu, Jingying Wang, E. Magnus Ohman, Marc S. Sabatine, Michelle L. O’Donoghue
Lipoprotein(a) [Lp(a)] is a presumed risk factor for atherosclerotic cardiovascular disease (ASCVD), and its levels are primarily genetically determined (∼70%-90%).1,2 As such, many guidelines and consensus groups recommend measuring Lp(a) levels only once in a person’s lifetime for risk stratification.3,4 However, data assessing the intraindividual variability of Lp(a) levels over time are limited
-
Obesity-Related Heart Failure With Preserved Ejection Fraction: Weighing the Benefit of Finerenone J. Am. Coll. Cardiol. (IF 21.7) Pub Date : 2024-12-10 Amanda R. Vest, Andrew J. Sauer
Section snippets Funding Support and Author DisclosuresDr Vest has received research grant funding from the National Heart, Lung, and Blood Institute (grant R01HL167113) and the National Center for Advancing Translational Sciences (grant RC2TR004377). Dr Sauer has received salary support for research activities from Saint Luke’s Mid America Heart Institute, a nonprofit academic research organization
-
2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee J. Am. Coll. Cardiol. (IF 21.7) Pub Date : 2024-12-10 Mark H. Drazner, Biykem Bozkurt, Leslie T. Cooper, Niti R. Aggarwal, Cristina Basso, Nicole M. Bhave, Alida L.P. Caforio, Vanessa M. Ferreira, Bettina Heidecker, Amy R. Kontorovich, Pilar Martín, Gregory A. Roth, Jennifer E. Van Eyk
Section snippets Solution Set Oversight CommitteeNicole M. Bhave, MD, FACC, ChairNiti R. Aggarwal, MD, FACCKatie Bates, ARNP, DNPJohn P. Erwin iii, MD, FACCMartha Gulati, MD, MS, FACCDharam J. Kumbhani, MD, SM, FACCGurusher S. Panjrath, MBBS, FACCBarbara Wiggins, PharmD, FACCMegan Coylewright, MD, MPH, FACC, Ex Officio Table of Contents Top 10 Key Takeaway Points 3 1.Introduction 4 2.Assumptions and
-
Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF J. Am. Coll. Cardiol. (IF 21.7) Pub Date : 2024-12-10 Jawad H. Butt, Alasdair D. Henderson, Pardeep S. Jhund, Brian L. Claggett, Akshay S. Desai, James Lay-Flurrie, Prabhakar Viswanathan, Andrea Lage, Markus F. Scheerer, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Johann Bauersachs, Cândida Fonseca, Mikhail N. Kosiborod, Gerard C.M. Linssen, Mark C. Petrie, Morten Schou, Subodh Verma, John J.V. McMurray
-
Successful diagnosis and surgical treatment of tuberculous pericarditis. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-11 Li Yang,Liqun He
-
Prognostic impact of inducible ischaemia in ischaemic left ventricular dysfunction: the REVIVED-BCIS2 trial. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-11 Holly Morgan,Muhummad Sohaib Nazir,Matthew E Li Kam Wa,Gerry P McCann,John P Greenwood,Adam K McDiarmid,Matthew Dodd,Matthew Ryan,Divaka Perera,Amedeo Chiribiri
-
Weekly Journal Scan: Pushing the boundaries of transcatheter aortic valve implantation in asymptomatic patients with severe aortic stenosis. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-11 Rocco Vergallo,Daniela Pedicino
-
Mediterranean diet, neutrophil count, and carotid intima-media thickness in secondary prevention: the CORDIOPREV study Eur. Heart J. (IF 37.6) Pub Date : 2024-12-11 Hatim Boughanem, José D Torres-Peña, Antonio Pablo Arenas-de Larriva, Juan L Romero-Cabrera, Purificación Gómez-Luna, Laura Martín-Piedra, Fernando Rodríguez-Cantalejo, Francisco J Tinahones, Elena M Yubero Serrano, Oliver Soehnlein, Pablo Perez-Martinez, Javier Delgado-Lista, José López-Miranda
Background and Aims Several studies have supported the role of innate immune system as a key factor in the sterile inflammation underlying the pathophysiology of atherosclerosis in mice. However, its involvement in humans remains unclear. This study aimed to explore the association between neutrophil count, and the intima-media thickness of common carotid arteries (IMT-CC), as well as the potential
-
The '10 commandments' of the 2024 European Society of Cardiology guidelines for the management of chronic coronary syndromes. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-11 Christiaan J M Vrints,Felicita Andreotti
-
Artificial intelligence in patients with atrial fibrillation to manage clinical complexity and comorbidities: the ARISTOTELES project. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-11 Giuseppe Boriani,Davide Antonio Mei,Gregory Y H Lip,
-
European Research Council-funded grant: unveiling the effect of chemicals on lipids. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-11 Tina Kold Jensen,Iben Have Beck,Christian Lars Lund
-
Illuminating data: how the new ESC Atlas can help chart a healthier future across Europe. Eur. Heart J. (IF 37.6) Pub Date : 2024-12-11 Judith Ozkan
-
Type 2 myocardial infarction: challenges in diagnosis and treatment Eur. Heart J. (IF 37.6) Pub Date : 2024-12-11 Andrew R Chapman, Caelan Taggart, Jasper Boeddinghaus, Nicholas L Mills, Keith A A Fox
The Fourth Universal Definition of Myocardial Infarction recommends a classification based on aetiology, in recognition that the underlying pathophysiology of myocardial infarction influences the approach to investigation and treatment. Type 1 myocardial infarction occurs due to atherosclerotic plaque rupture with thrombosis, whereas type 2 myocardial infarction occurs due to an imbalance in myocardial
-
Angiotensin Receptor-Neprilysin Inhibitor Prescribing Patterns in Patients Hospitalized for Heart Failure JAMA Cardiol. (IF 14.8) Pub Date : 2024-12-11 Pratyaksh K. Srivastava, Alexandra M. Klomhaus, Stephen J. Greene, Paul Heidenreich, Sabra C. Lewsey, Clyde W. Yancy, Gregg C. Fonarow
ImportanceAngiotensin receptor-neprilysin inhibition (ARNI) improves mortality among patients with heart failure with reduced ejection fraction (HFrEF), ie, those with an EF of 40% or less.ObjectiveTo describe national longitudinal trends in ARNI prescribing patterns among hospitalized patients with HFrEF.Design, Setting, and ParticipantsUsing data from the Get With The Guidelines–Heart Failure (GWTG-HF)
-
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV JAMA Cardiol. (IF 14.8) Pub Date : 2024-12-11 Márton Kolossváry, Samuel R. Schnittman, Markella V. Zanni, Kathleen V. Fitch, Carl J. Fichtenbaum, Judith A. Aberg, Gerald S. Bloomfield, Carlos D. Malvestutto, Judith Currier, Marissa R. Diggs, Christopher deFilippi, Allison Ross Eckard, Adrian Curran, Murat Centinbas, Ruslan Sadreyev, Borek Foldyna, Thomas Mayrhofer, Julia Karady, Jana Taron, Sara McCallum, Michael T. Lu, Heather J. Ribaudo, Pamela
ImportanceIn a mechanistic substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) randomized clinical trial, pitavastatin reduced noncalcified plaque (NCP) volume, but specific protein and gene pathways contributing to changes in coronary plaque remain unknown.ObjectiveTo use targeted discovery proteomics and transcriptomics approaches to interrogate biological pathways beyond